Triamcinolone Acetonide NDC 0168-0005

NDC codes

FDA NDC Directory

Product NDC (as listed)0168-0005Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00168-0005Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0168-0005-80	00168000580	80 g in 1 TUBE (0168-0005-80)Marketed from Feb 14, 1978

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamcinolone Acetonide
Generic name (nonproprietary): triamcinolone acetonide
Active ingredients: Triamcinolone acetonide — .25 mg/g
Dosage form: Ointment
Route: Topical
Labeler: E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 085691
Marketing start: Feb 14, 1978
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0168-0005_4ecf8bca-6585-4eed-88c7-c261a622d1cdSPL ID 4ecf8bca-6585-4eed-88c7-c261a622d1cdSPL set ID a5cc640f-c72d-49fa-b970-906c9ffd8629RxCUI 1085633, 1085636UNII F446C597KAUPC 0301680006154
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400168000580 followed by a unit qualifier and the quantity

Package 00168-0005-80. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 085691

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 085691
Product	Strength	Form · route	Labeler	Product NDC
Triamcinolone Acetonide	Triamcinolone acetonide 1 mg/g	OintmentTopical	E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC	0168-0006
Triamcinolone Acetonide	Triamcinolone acetonide .25 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-8841
Triamcinolone Acetonide	Triamcinolone acetonide .25 mg/g	OintmentTopical	Asclemed USA, Inc.	76420-360
Triamcinolone Acetonide	Triamcinolone acetonide 1 mg/g	OintmentTopical	Asclemed USA, Inc.	76420-361